Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CCAAT-Enhancer-Binding Proteins | 1 | 2020 | 287 | 0.650 |
Why?
|
| Cell Cycle | 3 | 2020 | 2932 | 0.560 |
Why?
|
| Receptors, CCR | 1 | 2016 | 37 | 0.540 |
Why?
|
| Chemokines, CC | 1 | 2016 | 282 | 0.490 |
Why?
|
| Neoplastic Stem Cells | 2 | 2019 | 1340 | 0.460 |
Why?
|
| Interleukin-17 | 1 | 2018 | 889 | 0.410 |
Why?
|
| Receptors, CXCR4 | 1 | 2016 | 728 | 0.400 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 727 | 0.390 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2022 | 1627 | 0.390 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2021 | 1876 | 0.390 |
Why?
|
| Lung Neoplasms | 3 | 2022 | 13209 | 0.350 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 1524 | 0.340 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2022 | 2822 | 0.260 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2023 | 139 | 0.260 |
Why?
|
| Cell Line, Tumor | 5 | 2022 | 16793 | 0.240 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 1616 | 0.230 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2022 | 69 | 0.210 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2023 | 255 | 0.210 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2022 | 124 | 0.200 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 10057 | 0.190 |
Why?
|
| Cell Proliferation | 3 | 2022 | 10392 | 0.180 |
Why?
|
| Blotting, Western | 2 | 2018 | 5042 | 0.180 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2023 | 591 | 0.170 |
Why?
|
| Gene Library | 1 | 2022 | 1060 | 0.170 |
Why?
|
| DNA, Complementary | 1 | 2022 | 1991 | 0.160 |
Why?
|
| Cell Movement | 2 | 2022 | 5182 | 0.160 |
Why?
|
| Tumor Microenvironment | 2 | 2022 | 3770 | 0.150 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5231 | 0.150 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 20890 | 0.150 |
Why?
|
| Computational Biology | 2 | 2020 | 3502 | 0.140 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 615 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2016 | 23278 | 0.130 |
Why?
|
| Stress, Physiological | 1 | 2023 | 1394 | 0.130 |
Why?
|
| Adipocytes | 1 | 2022 | 1180 | 0.130 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 3575 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 2455 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 2868 | 0.110 |
Why?
|
| Prognosis | 3 | 2020 | 29423 | 0.110 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 9372 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2023 | 2858 | 0.100 |
Why?
|
| Cell Separation | 1 | 2016 | 1720 | 0.090 |
Why?
|
| Phenotype | 2 | 2019 | 16478 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 6521 | 0.080 |
Why?
|
| DNA Replication | 1 | 2016 | 1408 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2022 | 12753 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 6066 | 0.070 |
Why?
|
| Gene Expression | 1 | 2020 | 7587 | 0.070 |
Why?
|
| Neoplasms | 1 | 2016 | 21887 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5847 | 0.070 |
Why?
|
| Humans | 10 | 2023 | 755533 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2021 | 5187 | 0.060 |
Why?
|
| Mice | 3 | 2023 | 80745 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 4875 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 5609 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 8439 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2789 | 0.060 |
Why?
|
| Hydroxylation | 1 | 2023 | 138 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 11028 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 18027 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2018 | 3779 | 0.050 |
Why?
|
| Apoptosis | 1 | 2018 | 9452 | 0.050 |
Why?
|
| Proline | 1 | 2023 | 456 | 0.050 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2021 | 95 | 0.050 |
Why?
|
| Sp1 Transcription Factor | 1 | 2021 | 141 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11606 | 0.050 |
Why?
|
| Animals | 3 | 2023 | 167149 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 21790 | 0.040 |
Why?
|
| Protein Stability | 1 | 2021 | 567 | 0.040 |
Why?
|
| Models, Biological | 1 | 2016 | 9452 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2023 | 621 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2021 | 345 | 0.040 |
Why?
|
| Female | 4 | 2022 | 387920 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2021 | 554 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2021 | 1748 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2021 | 1758 | 0.030 |
Why?
|
| Ischemia | 1 | 2023 | 1892 | 0.030 |
Why?
|
| Inflammation | 2 | 2023 | 10717 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13577 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2023 | 8321 | 0.030 |
Why?
|
| Male | 2 | 2018 | 356577 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 167376 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 218055 | 0.010 |
Why?
|
| Adult | 1 | 2016 | 217986 | 0.010 |
Why?
|
Concepts
(83)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_